360 ONE WAM Q2 FY26 PAT Up 27.7% to ₹316 Crore, UBS Collaboration Progresses

360 ONE WAM reported a strong Q2 FY26 performance with PAT rising 27.7% YoY to ₹316 Crore. Total revenue increased 31.5% YoY to ₹813 Crore. The company’s AUM reached ₹6,71,625 Crore. The integration of the wealth management business from UBS AG is progressing, with UBS AG subscribing to convertible warrants representing 4.95% stake in 360 ONE WAM.

Strong Financial Performance

360 ONE WAM announced robust financial results for Q2 FY26 (July-September 2025):

  • PAT: Increased 27.7% YoY to ₹316 Crore.
  • Total Revenue: Grew 31.5% YoY to ₹813 Crore.
  • Assets Under Management (AUM): Reached ₹6,71,625 Crore as of September 2025.
  • Annual Recurring Revenue (ARR) AUM: Increased 21.7% YoY to ₹2,95,324 Crore.

Segment Highlights

  • Wealth Management: ARR AUM rose to ₹2,03,208 Crore (+29.6% YoY), driven by growth across segments including 360 ONE Plus (+32.4% YoY) and Distribution and Lending (+26.3% YoY and +52.1% YoY, respectively).
  • Asset Management: ARR AUM increased to ₹92,116 Crore (+7.4% YoY), primarily from Private Equity (+21.1% YoY) and Real Assets (+39.7% YoY).

UBS AG Collaboration Update

The transfer of UBS AG’s India wealth management business was completed on September 29, 2025. UBS AG subscribed to convertible warrants, representing a 4.95% stake in 360 ONE WAM.

Key Financial Ratios

  • Tangible net worth stood at ₹6,195 Crore.
  • Tangible Return on Equity was at 20.6% in Q2 FY26.

Dividend Announcement

The Board approved a second interim dividend for FY 2025-26 of ₹6/- per equity share, with a record date of October 27, 2025.

ESOP Schemes Approved

The board approved the ‘360 ONE Employee Stock Option Scheme 2025 – Series 1’ and ‘360 ONE Employee Stock Option Scheme 2025 – Series 2’, subject to shareholder approval.

Disclaimer: Note that in relation to the above dividend and ESOP announcements, this extracted corporate disclosure lacks direct details on approval dates and may therefore not accurately reflect precise approval timelines.

Source: BSE

InvestyWise News
InvestyWise News
Covers market-moving news with speed and precision, delivering sharp insights to help readers stay ahead in the fast-paced world of stocks.

Latest articles

Related articles

Leave a reply

Please enter your comment!
Please enter your name here
Captcha verification failed!
CAPTCHA user score failed. Please contact us!